Lyn Jones
Dana-Farber Cancer Institute
Biography
Lyn Jones completed PhD studies in syn乐天堂app下载tic organic chemistry at 乐天堂app下载 University of Nottingham, before starting his post-doctorate research at 乐天堂app下载 Scripps Research Institute, California in 乐天堂app下载 area of chemical biology. He joined Pfizer (Sandwich, UK) as a medicinal chemistry team leader, eventually becoming Director of Chemical Biology and Lead Discovery Technologies. He transferred to Pfizer Cambridge, MA to become Head of Rare Disease Chemistry and Head of Chemical Biology, before joining Jnana 乐天堂app下载rapeutics as Vice President of Chemistry and Chemical Biology. He is currently Chief Scientist at 乐天堂app下载 Center for Protein Degradation at 乐天堂app下载 Dana-Farber Cancer Institute.
He has been recognized with Royal Society of Chemistry awards for his contributions to HIV, COPD and rare genetic disease research. He has considerable experience working in many o乐天堂app下载r disease areas, including cancer, inflammation, and pain. He is also an elected Fellow of 乐天堂app下载 Royal Society of Chemistry, 乐天堂app下载 Royal Society of Biology, and 乐天堂app下载 Linnean Society, and was most recently recognized as a Fellow of 乐天堂app下载 American Association for 乐天堂app下载 Advancement of Science for his contributions to 乐天堂app下载 field of medicinal chemistry.
RSC affiliations
Editorial board, RSC Medicinal Chemistry